On December 3, 2014, FDLI and the University of Maryland Schools of Law and Pharmacy will present Emerging Issues in FDA Law: Implementation of DQSA
Click here to register.
Use this code for a Policy and Medicine readers’ discount: DQSA122014
December 3, 2014 | Arnold & Porter | Washington, DC
This one-day conference focuses on the Drug Quality and Security Act and its two major issue areas: implementation of track and trace procedures and regulation of pharmacy compounding. The program brings together government workers, consultants and industry representatives to discuss implementation, FDA guidance and future considerations.
With guidance from expert speakers, participants will review the key parts of the act, recently released guidance from the FDA, implementation deadlines, and look ahead to future deadlines. The Drug Quality and Security Act will continue to have a significant impact on drug manufacturers, wholesalers and pharmacies. Join us to learn about specific requirements for all stakeholders throughout the drug distribution supply chain.
Click here for the day’s agenda.
Who Will Attend
- Attorneys, regulatory staff and compliance personnel who work for drug manufacturers, pharmacies, third party distributors, warehouses and distribution facilities.
- Regulatory and other scientists who work in pharmacy compounding
- Academics, consultants and other research organizations and the press who study and report on issues related to drug safety and pharmacy compounding.